These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20865695)

  • 21. Pharmacokinetics of letrozole in male and female rats: influence of complexation with hydroxybutenyl-beta cyclodextrin.
    Wempe MF; Buchanan CM; Buchanan NL; Edgar KJ; Hanley GA; Ramsey MG; Skotty JS; Rice PJ
    J Pharm Pharmacol; 2007 Jun; 59(6):795-802. PubMed ID: 17637172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vivo biodisposition of [14C]-quaternary ammonium-melphalan conjugate, a potential cartilage-targeted alkylating drug.
    Rapp M; Giraud I; Maurizis JC; Galmier MJ; Madelmont JC
    Bioconjug Chem; 2003; 14(2):500-6. PubMed ID: 12643763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies.
    Pinguet F; Culine S; Bressolle F; Astre C; Serre MP; Chevillard C; Fabbro M
    Clin Cancer Res; 2000 Jan; 6(1):57-63. PubMed ID: 10656432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degradation of NSC-281612 (4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde), an experimental antineoplastic agent: effects of pH, solvent composition, (SBE)7m-beta-CD, and HP-beta-CD on stability.
    Jumaa M; Chimilio L; Chinnaswamy S; Silchenko S; Stella VJ
    J Pharm Sci; 2004 Mar; 93(3):532-9. PubMed ID: 14762892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model.
    Glehen O; Stuart OA; Mohamed F; Sugarbaker PH
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):79-84. PubMed ID: 15048586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic analysis of 6-monoamino-beta-cyclodextrin after intravenous or oral administration to rats using a specific enzyme immunoassay.
    Créminon C; Djedaïni-Pilard F; Vienet R; Péan C; Grognet JM; Grassi J; Perly B; Pradelles P
    J Pharm Sci; 1999 Mar; 88(3):302-5. PubMed ID: 10052987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of the intravenous pharmacokinetics of a synthetic ozonide antimalarial in the presence of a modified cyclodextrin.
    Charman SA; Perry CS; Chiu FC; McIntosh KA; Prankerd RJ; Charman WN
    J Pharm Sci; 2006 Feb; 95(2):256-67. PubMed ID: 16374851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of melphalan in isolated limb perfusion.
    Norda A; Loos U; Sastry M; Goehl J; Hohenberger W
    Cancer Chemother Pharmacol; 1999; 43(1):35-42. PubMed ID: 9923539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of saquinavir after intravenous and oral dosing of saquinavir: hydroxybutenyl-beta-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
    Biomacromolecules; 2008 Jan; 9(1):305-13. PubMed ID: 18072746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of mean arterial blood pressure, heart rate, and sympathetic nerve activity in rabbits after administration of two formulations of etomidate.
    McIntosh MP; Narita H; Kameyama Y; Rajewski RA; Goto H
    Vet Anaesth Analg; 2007 May; 34(3):149-56. PubMed ID: 17444927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a sulfobutyl ether beta-cyclodextrin as a solubilizing/stabilizing agent for several drugs.
    Ueda H; Ou D; Endo T; Nagase H; Tomono K; Nagai T
    Drug Dev Ind Pharm; 1998 Sep; 24(9):863-7. PubMed ID: 9876538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac.
    Xu Y; Zhang C; Zhu X; Wang X; Wang H; Hu G; Fu Q; He Z
    Expert Opin Drug Deliv; 2019 Jun; 16(6):657-666. PubMed ID: 31033370
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of intravenous sulfobutylether7 -β-cyclodextrin on the pharmacokinetics of a series of adamantane-containing compounds.
    Leong NJ; Prankerd RJ; Shackleford DM; Mcintosh MP
    J Pharm Sci; 2015 Apr; 104(4):1492-8. PubMed ID: 25573540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-beta-cyclodextrin following subcutaneous injection in sheep.
    Wu Z; Tucker IG; Razzak M; Yang L; McSporran K; Medlicott NJ
    Int J Pharm; 2010 Sep; 397(1-2):96-102. PubMed ID: 20621175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
    Hegge AB; Másson M; Kristensen S; Tønnesen HH
    Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of melphalan, infused over a 24-hour period, in patients with advanced malignancies.
    Mougenot P; Pinguet F; Fabbro M; Culine S; Poujol S; Astre C; Bressolle F
    Cancer Chemother Pharmacol; 2004 Jun; 53(6):503-12. PubMed ID: 15007638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel/beta-cyclodextrin complexes for hyperthermic peritoneal perfusion - formulation and stability.
    Bouquet W; Ceelen W; Fritzinger B; Pattyn P; Peeters M; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2007 Jun; 66(3):391-7. PubMed ID: 17240125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights in cyclodextrin: surfactant mixed systems from the use of neutral and anionic cyclodextrin derivatives.
    García-Río L; Méndez M; Paleo MR; Sardina FJ
    J Phys Chem B; 2007 Nov; 111(44):12756-64. PubMed ID: 17939704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.